| INTASYL Phio Pharmaceuticals Corp.
88571383 08 Aug 2019 | on 15 Aug 2023
| Pharmaceutical preparations for the treatment of cancer Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of cancer | | | SAMCYPRONE PHIO PHARMACEUTICALS CORP.
86476105 10 Dec 2014 | on 21 Aug 2018 | Dermatological pharmaceutical products; Pharmaceutical preparations fo... Class 005 Class 005 Pharmaceutical Products Dermatological pharmaceutical products; Pharmaceutical preparations for treating alopecia; Pharmaceutical preparations for treating warts | | | P PHIO PHARMACEUTICALS Phio Pharmaceuticals Corp.
98584400 04 Jun 2024 | on 19 Dec 2024 | Therapeutic pharmaceuticals for use in the treatment of cancer Class 005 Class 005 Pharmaceutical Products The mark consists of stylized word "PHIO" stacked above the word "PHARMACEUTICALS" to the right of a stylized letter "P". | | | PHIO PHARMACEUTICALS Phio Pharmaceuticals Corp.
98576485 30 May 2024 | on 12 Dec 2024 | Therapeutic pharmaceuticals for use in the treatment of cancer Class 005 Class 005 Pharmaceutical Products Therapeutic pharmaceuticals for use in the treatment of cancer | | | DERMARK PHIO PHARMACEUTICALS CORP.
98250179 01 Nov 2023 | on 18 Jun 2024 | Pharmaceutical compositions for the treatment of cancer Class 005 Class 005 Pharmaceutical Products Pharmaceutical compositions for the treatment of cancer | | | DERMAPEX PHIO PHARMACEUTICALS CORP.
98250184 01 Nov 2023 | on 18 Jun 2024 | Pharmaceutical compositions for the treatment of cancer Class 005 Class 005 Pharmaceutical Products Pharmaceutical compositions for the treatment of cancer | | | INTASYL Phio Pharmaceuticals Corp.
98073145 06 Jul 2023 | on 18 Jun 2024 | Pharmaceutical preparations for the treatment of diseases and disorder... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, hematology and in tissue and organ regeneration, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, liver diseases and disorders, antifungal, anti-infective, antiviral preparations and antibiotics | | | PHIO PHARMACEUTICALS Phio Pharmaceuticals Corp.
97423827 23 May 2022 | on 12 Nov 2024 | Therapeutic pharmaceuticals for use in the treatment of cancer Class 005 Class 005 Pharmaceutical Products Therapeutic pharmaceuticals for use in the treatment of cancer | | | PHIO PHARMACEUTICALS PHIO PHARMACEUTICALS CORP.
88170269 26 Oct 2018 | on 27 Jun 2022 | Therapeutic pharmaceuticals for use in the treatment of cancer Class 005 Class 005 Pharmaceutical Products Therapeutic pharmaceuticals for use in the treatment of cancer | | | RXI PHIO PHARMACEUTICALS CORP.
85223019 21 Jan 2011 | on 03 Jun 2022 | Reagents for research purposes Class 001 Class 001 Chemical Products The mark consists of the letters "RXI" shown in white on a square background which has a perimeter line shown in purple, with a white line running around the interior of that purple perimeter line, with the "R" shown as an upper-case letter on a purple background, the "X" shown as a stylized letter in curved strokes suggesting a fragment of DNA on a background which is purple on the left and grey on the right, and the "I" shown as a lower-case letter on a grey background. | |